LA
NVO

Leonetti & Associates’s Novo Nordisk NVO Stock Holding History

Leonetti & Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-183,750
Closed -$4.94M – 44
2016
Q2 		$4.94M Sell
183,750
-4,750
-3% -$130K 1.42% 27
2016
Q1 		$5.11M Buy
188,500
+8,500
+5% +$228K 1.49% 25
2015
Q4 		$5.23M Buy
180,000
+1,500
+0.8% +$41.5K 1.56% 23
2015
Q3 		$4.84M Hold
178,500
– – 1.53% 22
2015
Q2 		$4.89M Buy
178,500
+12,300
+7% +$346K 1.4% 27
2015
Q1 		$4.44M Buy
+166,200
New +$3.83M 1.32% 27

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Leonetti & Associates's NVO Position: Q3 2016 in Review

Leonetti & Associates sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 183,750 shares — an estimated $4.94M sold.

Leonetti & Associates first reported a position in NVO in Q1 2015 and held it in 6 quarters. The position peaked at $5.23M in Q4 2015. 511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Leonetti & Associates reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Leonetti & Associates sold 183,750 Novo Nordisk shares in Q3 2016, an estimated $4.94M.
  • Leonetti & Associates first reported a position in Novo Nordisk in Q1 2015 and held it in 6 quarters.
  • Leonetti & Associates's Novo Nordisk position peaked at $5.23M in Q4 2015.
  • 511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Leonetti & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.